Company news
Avalon GloboCare Corp. news in 2021
Avalon GloboCare Corp.'s news releases, calls and decks from 2021, newest first.
Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
December 21, 2021
Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development
December 8, 2021
Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
October 13, 2021
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases
October 6, 2021
Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain Cancer
June 30, 2021
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
June 13, 2021
Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ Platform
March 28, 2021
Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis
March 21, 2021